Immunome Stock Volatility

IMNM Stock  USD 22.86  0.55  2.35%   
Immunome appears to be not too volatile, given 3 months investment horizon. Immunome holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13 % return per unit of risk over the last 3 months. By evaluating Immunome's technical indicators, you can evaluate if the expected return of 0.64% is justified by implied risk. Please utilize Immunome's Downside Deviation of 4.37, market risk adjusted performance of 0.5491, and Risk Adjusted Performance of 0.1287 to validate if our risk estimates are consistent with your expectations.

Sharpe Ratio = 0.13

High ReturnsBest Equity
Good Returns
Average Returns
Small ReturnsIMNM
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns
Based on monthly moving average Immunome is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunome by adding it to a well-diversified portfolio.
Key indicators related to Immunome's volatility include:
90 Days Market Risk
Chance Of Distress
90 Days Economic Sensitivity
Immunome Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Immunome daily returns, and it is calculated using variance and standard deviation. We also use Immunome's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Immunome volatility.

ESG Sustainability

While most ESG disclosures are voluntary, Immunome's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Immunome's managers and investors.
Environmental
Governance
Social
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Immunome can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Immunome at lower prices. For example, an investor can purchase Immunome stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Immunome's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns. Main indicators related to Immunome's market risk premium analysis include:
Beta
1.36
Alpha
0.61
Risk
4.92
Sharpe Ratio
0.13
Expected Return
0.64

Moving together with Immunome Stock

  0.83DSGN Design TherapeuticsPairCorr
  0.83ENGN enGene Holdings CommonPairCorr
  0.74IMMP Immutep Ltd ADRPairCorr
  0.72MRKR Marker TherapeuticsPairCorr
  0.72AVE Avecho BiotechnologyPairCorr
  0.87ANNX AnnexonPairCorr

Moving against Immunome Stock

  0.86ABP Abpro HoldingsPairCorr
  0.82GNLX Genelux CommonPairCorr
  0.78LYRA Lyra TherapeuticsPairCorr
  0.76IMRN Immuron Ltd ADRPairCorr
  0.74KURA Kura OncologyPairCorr
  0.71DWTX Dogwood TherapeuticsPairCorr
  0.71QSI QuantumSiPairCorr
  0.7EDIT Editas Medicine Earnings Call This WeekPairCorr
  0.6EVGN EvogenePairCorr

Immunome Market Sensitivity And Downside Risk

Immunome's beta coefficient measures the volatility of Immunome stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Immunome stock's returns against your selected market. In other words, Immunome's beta of 1.36 provides an investor with an approximation of how much risk Immunome stock can potentially add to one of your existing portfolios. Immunome shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Immunome's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Immunome's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
Check current 90 days Immunome correlation with market (Dow Jones Industrial)
α0.61   β1.36
3 Months Beta |Analyze Immunome Demand Trend
Check current 90 days Immunome correlation with market (Dow Jones Industrial)

Immunome Volatility and Downside Risk

Immunome standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Using Immunome Put Option to Manage Risk

Put options written on Immunome grant holders of the option the right to sell a specified amount of Immunome at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Immunome Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Immunome's position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Immunome will be realized, the loss incurred will be offset by the profits made with the option trade.

Immunome's PUT expiring on 2026-04-17

   Profit   
       Immunome Price At Expiration  

Current Immunome Insurance Chain

DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Put
IMNM260417P00007500-0.0430460.001546362026-04-170.0 - 4.90.0View
Put
IMNM260417P00010000-0.0816710.00344232026-04-170.0 - 4.90.0View
Put
IMNM260417P00012500-0.1239390.00979782026-04-170.05 - 4.00.0View
Put
IMNM260417P00014000-0.1469570.007561912026-04-170.0 - 4.90.0View
Put
IMNM260417P00015000-0.0892120.01757322026-04-170.3 - 0.60.0View
Put
IMNM260417P00016000-0.1857150.015661122026-04-170.25 - 4.90.0View
Put
IMNM260417P00017500-0.2153110.02016242026-04-170.0 - 2.50.0View
Put
IMNM260417P00020000-0.2751990.0184411102026-04-170.0 - 4.90.0View
Put
IMNM260417P00022000-0.3568050.042662202026-04-170.4 - 4.90.0View
Put
IMNM260417P00025000-0.5012710.049379152026-04-172.0 - 6.20.0View
Put
IMNM260417P00035000-0.8606220.02975742026-04-179.5 - 14.40.0View
View All Immunome Options

Immunome Stock Volatility Analysis

Volatility refers to the frequency at which Immunome stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Immunome's price changes. Investors will then calculate the volatility of Immunome's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Immunome's volatility:

Historical Volatility

This type of stock volatility measures Immunome's fluctuations based on previous trends. It's commonly used to predict Immunome's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Immunome's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Immunome's to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Immunome Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Immunome Projected Return Density Against Market

Given the investment horizon of 90 days the stock has the beta coefficient of 1.3626 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Immunome will likely underperform.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Immunome or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Immunome's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Immunome stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Immunome has an alpha of 0.6073, implying that it can generate a 0.61 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
Immunome's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how immunome stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Immunome Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract investor attention to the company. This positive attention may impact the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Immunome Stock Risk Measures

Given the investment horizon of 90 days the coefficient of variation of Immunome is 769.13. The daily returns are distributed with a variance of 24.17 and standard deviation of 4.92. The mean deviation of Immunome is currently at 3.52. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.79
α
Alpha over Dow Jones
0.61
β
Beta against Dow Jones1.36
σ
Overall volatility
4.92
Ir
Information ratio 0.13

Immunome Stock Return Volatility

Immunome historical daily return volatility represents how much of Immunome stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 4.9163% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7721% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BLRXGOVX
AIMDGOVX
AIMDBLRX
LPCNTHAR
AIMDTHAR
  

High negative correlations

LPCNGOVX
LPCNBLRX
LPCNAIMD
THARGOVX
THARBLRX

Risk-Adjusted Indicators

There is a big difference between Immunome Stock performing well and Immunome Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immunome's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

About Immunome Volatility

Volatility is a rate at which the price of Immunome or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Immunome may increase or decrease. In other words, similar to Immunome's beta indicator, it measures the risk of Immunome and helps estimate the fluctuations that may happen in a short period of time. So if prices of Immunome fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for Next Year
Market Cap560.5 M588.5 M
Immunome's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Immunome Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Immunome's price varies over time.

3 ways to utilize Immunome's volatility to invest better

Higher Immunome's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Immunome stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Immunome stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Immunome investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Immunome's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Immunome's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Immunome Investment Opportunity

Immunome has a volatility of 4.92 and is 6.39 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of Immunome is lower than 44 percent of all global equities and portfolios over the last 90 days. You can use Immunome to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Immunome to be traded at $21.95 in 90 days.

Poor diversification

The correlation between Immunome and DJI is 0.75 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and DJI in the same portfolio, assuming nothing else is changed.

Immunome Additional Risk Indicators

The analysis of Immunome's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Immunome's investment and either accepting that risk or mitigating it. Along with some common measures of Immunome stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Immunome Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Immunome as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Immunome's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Immunome's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Immunome.
When determining whether Immunome is a strong investment it is important to analyze Immunome's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Immunome's future performance. For an informed investment choice regarding Immunome Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunome. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Immunome Stock, please use our How to Invest in Immunome guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Will Biotechnology sector continue expanding? Could Immunome diversify its offerings? Factors like these will boost the valuation of Immunome. Market participants price Immunome higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Immunome data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(2.96)
Revenue Per Share
0.122
Quarterly Revenue Growth
0.698
Return On Assets
(0.46)
Return On Equity
(0.93)
Understanding Immunome requires distinguishing between market price and book value, where the latter reflects Immunome's accounting equity. The concept of intrinsic value - what Immunome's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Immunome's price substantially above or below its fundamental value.
Please note, there is a significant difference between Immunome's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunome is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Immunome's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.